Home
Unity Biotechnology

Unity Biotechnology Market Share Analysis for April 2026

Unity Biotechnology, Inc. is a publicly traded American biotechnology company that develops drugs that target senescent cells.

Health > Biotechnology and Pharmaceuticals

Domainunitybiotechnology.com

Year Founded2011

Employees51 - 200

Annual Revenue$2M - $5M

Unity Biotechnology

Unity Biotechnology (including company regionals)

unitybiotechnology.com

See more website traffic and engagement information

Unity Biotechnology Revenue up to April 2026 is 2M - 5M

revenue generated by Unity Biotechnology top domains

Unity Biotechnology top domains revenue over 3 years

Revenue for Unity Biotechnology top domains

unitybiotechnology.com2M - 5M

See more with Sales Intelligence

Total visits to Unity Biotechnology's top domains

Understand Unity Biotechnology market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

unitybiotechnology.com1.7K

See more with Sales Intelligence

Avg. visit duration in Unity Biotechnology's top domains

Analyze Unity Biotechnology engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

unitybiotechnology.com00:00:33

See more with Sales Intelligence

Avg. pageviews on Unity Biotechnology's top domains

See how Unity Biotechnology keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

unitybiotechnology.com1.44

See more with Sales Intelligence

Unity Biotechnology top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Unity Biotechnology

These are the website technologies, by industry, used by Unity Biotechnology top domains

Widget (4)

Twemoji

Business Solutions (2)

FreshWorks

Email Services (2)

G Suite

Advertising (1)

PubMatic

More Technologies

9

See all

News & Signals from Unity Biotechnology

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsUnity Biotechnology Inc is developing senolytic therapies to clear senescent cells on May 14th '25.UNITY Biotechnology, developing senolytic therapies to clear senescent cells from aged tissues, is now one of the higher profile companies to run out of funding.

NewsUnity Biotechnology Inc attends event ARVO 2025 Annual Meeting.UNITY Biotechnology to present at the ARVO 2025 Annual Meeting.

NewsUnity Biotechnology Inc hired Yehia Hashad as M.D., executive vice president of research and development and chief medical officer on Mar 10th '25.SAN FRANCISCO, March 10, 2025 (GLOBE NEWSWIRE) - UNITY Biotechnology, Inc. ("UNITY") [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that Yehia Hashad, M.D., executive vice president of research and development and chief medical officer at Bausch + Lomb, has been appointed to the Company's board of directors and as a member of its science committee.